HLA-C Antikörper
-
- Target Alle HLA-C Antikörper anzeigen
- HLA-C (Major Histocompatibility Complex Class I C (HLA-C))
-
Reaktivität
- Human, Non-Human Primate
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-C Antikörper ist unkonjugiert
-
Applikation
- Immunoprecipitation (IP), Flow Cytometry (FACS)
- Verwendungszweck
- Anti-HLA-C Purified
- Spezifität
- The mouse monoclonal antibody DT-9 recognizes an extracellular epitope on HLA-C member of MHC class I molecules. It does not crossreact with HLA-A or HLA-B allotypes.
- Aufreinigung
- Purified by protein-A affinity chromatography.
- Immunogen
- Purified MHC class I molecules of tamarin origin
- Klon
- DT-9
- Isotyp
- IgG2b
- Top Product
- Discover our top product HLA-C Primärantikörper
-
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 48-305) antibody
HLA-C Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 25-308) antibodyHLA-C Reaktivität: Human ELISA, WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 62-306) antibodyHLA-C Reaktivität: Human ELISA, WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 38-62), (C-Term) antibodyHLA-C Reaktivität: Human, Maus, Ratte WB, ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 48-305) antibodyHLA-C Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C4 unconjugated
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 200-306) antibodyHLA-C Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Major Histocompatibility Complex Class I C (HLA-C) antibody (PE)HLA-C Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal DT-9 PE
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 1-366) antibodyHLA-C Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 25-308) antibody (Biotin)HLA-C Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal Biotin
anti-Major Histocompatibility Complex Class I C (HLA-C) (AA 66-93) antibodyHLA-C Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB21680 unconjugated
-
- Applikationshinweise
- Flow cytometry: Recommended dilution: 1-4 μg/mL.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 mg/mL
- Buffer
- Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2-8°C. Do not freeze.
-
- Target
- HLA-C (Major Histocompatibility Complex Class I C (HLA-C))
- Andere Bezeichnung
- HLA-C (HLA-C Produkte)
- Hintergrund
- Major histocompatibility complex, class I, C,HLA-C, a member of MHC class I glycoproteins, is one of polymorphysm typing targets, which are important for transplantation. The HLA system plays an important role in the occurrence and outcome of infectious diseases. The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population. It has been described that HLA-C interacts with human herpesvirus 8 MIR1 protein.,HLC-C, D6S204, PSORS1, HLA-JY3
- Gen-ID
- 3107
- UniProt
- P10321
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-
